Evaluation of the UroVysion Test in Predicting Recurrence and/or Progression of Disease in Patients Receiving initial BCG for Primary High Grade Ta-T1 and CIS Urothelial Carcinoma of the Bladder

Administered By

Awarded By

Contributors

Start/End

  • December 1, 2013 - May 31, 2019